Pitanium Delisted by Nasdaq; potential OTC trading remains uncertain
Jul 10, 2026, 4:11 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Delisting from Nasdaq substantially reduces liquidity and may force a shift to OTC. Absence of a listed venue typically compresses the stock’s trading multiple and raises the cost of capital; historical patterns show delistings often lead to at least near-term price weakness and elevated volatility, especially for small-cap issuers with limited OTC depth.
AI summary
What happened, with direct paths to the underlying reporting
PTNM received a Nasdaq delisting determination dated July 7, 2026 after the SEC’s 2025 trading suspension tied to manipulation concerns. If PTNM does not appeal by July 14, Nasdaq will suspend trading on July 16 and file Form 25-NSE to remove the listing. Delisting could push the stock to OTC markets, with uncertain liquidity despite ongoing operations.
Nasdaq delists PTNM; delisting letter dated July 7, 2026.
Trading suspension set for July 16 unless PTNM appeals by July 14.
Post-delisting, PTNM may trade OTC with uncertain liquidity.
Company asserts ongoing business operations and financial conditions are unaffected.
SEC had suspended trading on Oct 3, 2025 due to potential manipulation; Nasdaq halted trading.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
